The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review

E-ISSN： 1532-6535|91|3|542-549

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 542-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 17-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic (PBPK) Modeling in Children

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 40-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically‐based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 247-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting Drug–Drug Interactions Involving Multiple Mechanisms Using Physiologically Based Pharmacokinetic Modeling: A Case Study With Ruxolitinib

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 177-185

John Wiley & Sons Inc

Access to resources Recommend Favorite